Literature DB >> 17718107

Melkersson-Rosenthal syndrome: a form of pseudoangioedema.

Charlene Kakimoto1, Chad Sparks, Andrew A White.   

Abstract

BACKGROUND: Melkersson-Rosenthal syndrome is an unusual cause of facial swelling that can be confused with angioedema.
OBJECTIVE: To describe a young woman with facial swelling initially considered to be angioedema.
METHODS: A biopsy specimen of the eyelid demonstrated findings consistent with Melkersson-Rosenthal syndrome.
RESULTS: After reviewing the differential diagnosis of pseudoangioedema, a presumptive diagnosis of Melkersson-Rosenthal syndrome was made. The patient was successfully treated with infliximab for Melkersson-Rosenthal syndrome. Owing to medication adverse effects, infliximab treatment was discontinued. Treatment was then continued with adalimumab, with good effect and without adverse events.
CONCLUSIONS: We report the case of a patient with Melkersson-Rosenthal syndrome presenting as angioedema. Furthermore, we report the first successful treatment of Melkersson-Rosenthal syndrome with adalimumab.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17718107     DOI: 10.1016/S1081-1206(10)60643-6

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  3 in total

Review 1.  Biological agents: what they are, how they affect oral health and how they can modulate oral healthcare.

Authors:  E Georgakopoulou; C Scully
Journal:  Br Dent J       Date:  2015-07       Impact factor: 1.626

2.  An extraordinary form of the Melkersson-Rosenthal syndrome successfully treated with the tumour necrosis factor-α blocker adalimumab.

Authors:  Juergen Stein; Alexander Paulke; Beate Schacher; Matthias Noehte
Journal:  BMJ Case Rep       Date:  2014-05-14

3.  Treatment of orofacial granulomatosis: a case report.

Authors:  Maaz B Badshah; Saqib Walayat; Umair Ahmed; Sonu Dhillon; Sherri Yong; Sunanda Kane; Shoba Thievanayagam
Journal:  J Med Case Rep       Date:  2017-10-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.